美的與上海青浦區籤15億人幣具身智能技術平臺項目合作協議
美的集團(00300.HK)(000333.SZ)與上海市青浦區日前在「2025世界人工智能大會暨人工智能全球治理高級別會議」閉幕式上,正式簽署一項總投資額達15億元人民幣的具身智能技術平臺項目合作協議,深化人工智能領域佈局,推動長三角創新樞紐建設。
此次簽約的具身智能技術平臺項目聚焦於家庭和工業兩大核心場景,旨在研發能夠適應複雜家居環境和滿足智能製造升級需求的具身智能設備。項目依託「數據-模型-評測」三位一體的技術方案,通過「技術突破+場景落地」的雙輪驅動模式,推動智能服務生態從實驗室走向家庭與工廠,解鎖「人機共生」新場景。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.